#104, Decoding the Immune System with AI, Adam Laing from IMU Biosciences
On today’s episode we learn all about the immune system with Adam Laing, Co-founder & Chief Scientific Officer of IMU Biosciences, as he joins Alex Merwin, Head of Growth for Healthcare & Life Science Startups at AWS, on the AWS Health Innovation Podcast. IMU Biosciences is transforming our understanding of the immune system by leveraging AI-powered immune profiling to create unprecedented insights into health and disease, to advance precision medicine through collaborations with leading pharma, research organizations, and academic institutions.
1. How is IMU Biosciences unlocking immune insights?
- IMU Biosciences’ pioneering technology measures 80 million data points across 2,000 immune cell subsets, from a small blood sample, providing unprecedented resolution into an individual’s immune profile. This enables precision medicine approaches across disease areas like cancer, autoimmunity, and cell therapy.
2. What is the potential of predictive immune profiling?
- By deeply characterizing immune systems, IMU aims to predict disease progression and treatment responses. Their machine learning analytics identify immune signatures that can stratify patients based on how effectively they will respond to therapies.
3. How does IMU Biosciences foster a collaborative culture?
- With a team spanning immunology, data science, engineering, and operations, IMU fosters a collaborative culture focused on solving complex problems. Their network and reputation helped secure early industry partnerships.
4. What is IMU Biosciences’ vision for scaling precision immunology?
- After demonstrating their technology’s potential during COVID-19 research, IMU raised a Series A to commercialize and build a predictive immune data platform. Their long-term vision is enabling preventative screening for disease risk.
5. How does IMU Biosciences leverage advances in flow cytometry?
- IMU leverages advances in flow cytometry instrumentation, labeling 75 markers to phenotype cells at unprecedented resolution. Robust processes ensure scalability by accounting for technical variability across samples.
Learn more about IMU Biosciences here to explore their pioneering work in unlocking the complexity of the immune system and advancing precision medicine.
Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation.
Please take a moment and let us know what you think of the podcast, access our feedback survey here.
